First Header Logo Second Header Logo

Connection

Lance Miller to Cyclin-Dependent Kinase Inhibitor p57

Back to Details
This is a "connection" page, showing publications Lance Miller has written about Cyclin-Dependent Kinase Inhibitor p57.
Lance Miller
Connection Strength
0.085
Cyclin-Dependent Kinase Inhibitor p57
  1. Yang X, Karuturi RK, Sun F, Aau M, Yu K, Shao R, Miller LD, Tan PB, Yu Q. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS One. 2009; 4(4):e5011.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.